← Home / Tonix Pharmaceuticals Holding Corp. (TNXP)
Stock Analysis
Tonix Pharmaceuticals Holding Corp. (TNXP)
TNXP
TNXP · Market data
10.01 -0.79%
Track TNXP in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when TNXP price is:
52W Range Position
1%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-02 14:45 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
11.80
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
21
●
Management / Board
MEDIUM
TNXP board and management update
Sullivan informed Tonix Pharmaceuticals Holding Corp.
8-K Filing • SEC EDGAR
MAY
11
●
Financial Results
HIGH
Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and
Tonix Pharmaceuticals Holding Corp.
8-K Filing • SEC EDGAR
MAY
7
●
Management / Board
MEDIUM
TNXP board and management update
(e) On May 7, 2026, Tonix Pharmaceuticals Holding Corp.
8-K Filing • SEC EDGAR
What's Driving TNXP?
📈 Technical recovery is improving
Momentum is Neutral. Watch 11.80 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
—
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
40.2
Price Chart
TNXP — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$142.2M
Company size
EV
$-31.8M
Debt-adjusted value
P/E
-1.0
Not meaningful
P/S
8.1
Balanced
P/B
0.6
Low book multiple
EV/Sales
-1.8
Not meaningful
EV/EBIT
0.2
Low multiple
P/FCF
-1.1
Not meaningful
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
6.88M
↗ Strong
📈 Net Income
-40.19M
↘ Negative
🧮 EPS (Basic)
-2.93
↘ Negative
Tonix Pharmaceuticals Holding Corp.
Related Opportunities